What's in EuroFarma's pipeline?

EuroFarma has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with EuroFarma's portfolio?

Top competitors by shared drug class: , Aqua Pharms, Astellas Pharma, AstraZeneca K.K., Generic (originally Merck).

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/eurofarma.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

EuroFarma — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EuroFarma (Private) pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

Private (Private) 2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Fluocinolone Acetonide	FLUOCINOLONE	marketed	Corticosteroid [EPC]		Immunology	2016-01-01
Derma-Smoothe/Fs	FLUOCINOLONE ACETONIDE	marketed	Corticosteroid [EPC]	Glucocorticoid receptor	Oncology	1963-01-01

Therapeutic area mix

Immunology · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

2027-08-12 — Derma-Smoothe/Fs · 8871241 · Formulation · US
2028-01-12 — Derma-Smoothe/Fs · 7998108 · Formulation · US
2028-11-07 — Derma-Smoothe/Fs · 9849027 · Formulation · US

Competitive overlap (companies sharing drug classes)

· 1 shared drug class
Aqua Pharms · 1 shared drug class
Astellas Pharma · 1 shared drug class
AstraZeneca K.K. · 1 shared drug class
Generic (originally Merck) · 1 shared drug class
Generic (originally Merck/Upjohn) · 1 shared drug class
Generic (originally Schering) · 1 shared drug class
National Jewish Health · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for EuroFarma:

Cite this brief

Drug Landscape (2026). EuroFarma — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/eurofarma. Accessed 2026-06-09.